nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—Oxymetazoline—HTR2A—conduct disorder	0.07	1	CrCbGaD
Xylometazoline—HTR1D—Serotonin receptors—HTR2A—conduct disorder	0.037	0.0398	CbGpPWpGaD
Xylometazoline—HTR1B—Serotonin receptors—HTR2A—conduct disorder	0.0363	0.039	CbGpPWpGaD
Xylometazoline—HTR1D—Monoamine GPCRs—DRD4—conduct disorder	0.0253	0.0272	CbGpPWpGaD
Xylometazoline—HTR1B—Monoamine GPCRs—DRD4—conduct disorder	0.0247	0.0266	CbGpPWpGaD
Xylometazoline—ADRA1D—Monoamine GPCRs—DRD4—conduct disorder	0.0216	0.0233	CbGpPWpGaD
Xylometazoline—HTR1D—Amine ligand-binding receptors—DRD4—conduct disorder	0.0212	0.0228	CbGpPWpGaD
Xylometazoline—HTR1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0208	0.0224	CbGpPWpGaD
Xylometazoline—ADRA2B—Monoamine GPCRs—DRD4—conduct disorder	0.0195	0.021	CbGpPWpGaD
Xylometazoline—ADRA2C—Monoamine GPCRs—DRD4—conduct disorder	0.0182	0.0196	CbGpPWpGaD
Xylometazoline—ADRA1D—Amine ligand-binding receptors—DRD4—conduct disorder	0.0182	0.0195	CbGpPWpGaD
Xylometazoline—ADRA1B—Monoamine GPCRs—DRD4—conduct disorder	0.0179	0.0193	CbGpPWpGaD
Xylometazoline—HTR1D—Monoamine GPCRs—HTR2A—conduct disorder	0.0165	0.0177	CbGpPWpGaD
Xylometazoline—ADRA2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0164	0.0176	CbGpPWpGaD
Xylometazoline—HTR1B—Monoamine GPCRs—HTR2A—conduct disorder	0.0161	0.0174	CbGpPWpGaD
Xylometazoline—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.0159	0.0171	CbGpPWpGaD
Xylometazoline—ADRA2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.0153	0.0165	CbGpPWpGaD
Xylometazoline—ADRA1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0151	0.0162	CbGpPWpGaD
Xylometazoline—ADRA2A—Monoamine GPCRs—DRD4—conduct disorder	0.0148	0.0159	CbGpPWpGaD
Xylometazoline—ADRA1D—Monoamine GPCRs—HTR2A—conduct disorder	0.0141	0.0152	CbGpPWpGaD
Xylometazoline—HTR1D—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0139	0.0149	CbGpPWpGaD
Xylometazoline—HTR1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0136	0.0146	CbGpPWpGaD
Xylometazoline—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0134	0.0144	CbGpPWpGaD
Xylometazoline—ADRA2B—Monoamine GPCRs—HTR2A—conduct disorder	0.0127	0.0137	CbGpPWpGaD
Xylometazoline—ADRA2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.0125	0.0134	CbGpPWpGaD
Xylometazoline—ADRA2C—Monoamine GPCRs—HTR2A—conduct disorder	0.0119	0.0128	CbGpPWpGaD
Xylometazoline—ADRA1D—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0119	0.0128	CbGpPWpGaD
Xylometazoline—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.0117	0.0126	CbGpPWpGaD
Xylometazoline—ADRA2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0107	0.0115	CbGpPWpGaD
Xylometazoline—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.0104	0.0112	CbGpPWpGaD
Xylometazoline—ADRA2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.01	0.0108	CbGpPWpGaD
Xylometazoline—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00984	0.0106	CbGpPWpGaD
Xylometazoline—ADRA2A—Monoamine GPCRs—HTR2A—conduct disorder	0.00966	0.0104	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Other—DRD4—conduct disorder	0.00961	0.0103	CbGpPWpGaD
Xylometazoline—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00874	0.0094	CbGpPWpGaD
Xylometazoline—ADRA2A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00812	0.00873	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00746	0.00802	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0073	0.00785	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00638	0.00686	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Other—HTR2A—conduct disorder	0.00627	0.00674	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00576	0.0062	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—CGA—conduct disorder	0.00568	0.00611	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—CGA—conduct disorder	0.00556	0.00598	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00538	0.00579	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0053	0.0057	CbGpPWpGaD
Xylometazoline—HTR1D—G alpha (i) signalling events—DRD4—conduct disorder	0.00525	0.00565	CbGpPWpGaD
Xylometazoline—HTR1B—G alpha (i) signalling events—DRD4—conduct disorder	0.00514	0.00553	CbGpPWpGaD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00488	0.00524	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—CGA—conduct disorder	0.00486	0.00523	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00477	0.00513	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00471	0.00506	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.00439	0.00472	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00437	0.0047	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00418	0.00449	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00417	0.00449	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.0041	0.00441	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00409	0.0044	CbGpPWpGaD
Xylometazoline—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.00406	0.00437	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00403	0.00434	CbGpPWpGaD
Xylometazoline—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.00379	0.00408	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00377	0.00405	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00358	0.00385	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00358	0.00384	CbGpPWpGaD
Xylometazoline—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.00352	0.00379	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00352	0.00378	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00346	0.00372	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00333	0.00358	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00323	0.00347	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—CGA—conduct disorder	0.00321	0.00345	CbGpPWpGaD
Xylometazoline—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00318	0.00342	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—DRD4—conduct disorder	0.00318	0.00342	CbGpPWpGaD
Xylometazoline—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00315	0.00339	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—CGA—conduct disorder	0.00314	0.00338	CbGpPWpGaD
Xylometazoline—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00311	0.00335	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—DRD4—conduct disorder	0.00311	0.00335	CbGpPWpGaD
Xylometazoline—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.00308	0.00331	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00308	0.00331	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00302	0.00324	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00297	0.00319	CbGpPWpGaD
Xylometazoline—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00292	0.00314	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—CGA—conduct disorder	0.00292	0.00313	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00286	0.00307	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—CGA—conduct disorder	0.00285	0.00307	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00275	0.00295	CbGpPWpGaD
Xylometazoline—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00273	0.00293	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00272	0.00293	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00272	0.00293	CbGpPWpGaD
Xylometazoline—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00267	0.00287	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00264	0.00283	CbGpPWpGaD
Xylometazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00261	0.00281	CbGpPWpGaD
Xylometazoline—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.0026	0.00279	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.00249	0.00268	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00248	0.00267	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00246	0.00264	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00246	0.00264	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00245	0.00263	CbGpPWpGaD
Xylometazoline—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00233	0.00251	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00232	0.0025	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00232	0.00249	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0023	0.00247	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.0023	0.00247	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.00228	0.00245	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00226	0.00243	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.00226	0.00243	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.00225	0.00242	CbGpPWpGaD
Xylometazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00211	0.00226	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.0021	0.00226	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	0.00208	0.00223	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.00207	0.00223	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	0.00203	0.00219	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00203	0.00218	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00201	0.00216	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00201	0.00216	CbGpPWpGaD
Xylometazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00197	0.00212	CbGpPWpGaD
Xylometazoline—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00194	0.00208	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.00188	0.00202	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00186	0.00201	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.00186	0.00201	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.00184	0.00198	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	0.0018	0.00193	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.00178	0.00191	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	0.00176	0.00189	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CGA—conduct disorder	0.00172	0.00185	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00172	0.00185	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.00171	0.00184	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CGA—conduct disorder	0.00169	0.00181	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—DRD4—conduct disorder	0.00163	0.00176	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.0016	0.00172	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—DRD4—conduct disorder	0.0016	0.00172	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0016	0.00172	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.00154	0.00165	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.0015	0.00161	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CGA—conduct disorder	0.00149	0.0016	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.00147	0.00159	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.00147	0.00158	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.0014	0.0015	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.00139	0.00149	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—WASF1—conduct disorder	0.00138	0.00148	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—WASF1—conduct disorder	0.00135	0.00145	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.00133	0.00143	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.00131	0.00141	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.0013	0.0014	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.00128	0.00137	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.00126	0.00136	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.00124	0.00134	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.00122	0.00132	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.00122	0.00131	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CGA—conduct disorder	0.00121	0.0013	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.00118	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.00118	0.00127	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	0.00117	0.00126	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.00116	0.00125	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	0.00115	0.00123	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.00113	0.00122	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.00109	0.00117	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.00107	0.00115	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	0.00107	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.00105	0.00113	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	0.00104	0.00112	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.00103	0.00111	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.00101	0.00109	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.001	0.00108	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.000996	0.00107	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.00098	0.00105	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—DRD4—conduct disorder	0.000964	0.00104	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.000957	0.00103	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—DRD4—conduct disorder	0.000944	0.00102	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.000912	0.00098	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.000906	0.000974	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000871	0.000936	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.000847	0.00091	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000833	0.000896	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.000825	0.000887	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.000823	0.000885	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.000809	0.00087	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.000769	0.000827	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—EP300—conduct disorder	0.00076	0.000817	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.000757	0.000814	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.000745	0.000801	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00074	0.000796	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—EP300—conduct disorder	0.00071	0.000763	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.000696	0.000748	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000688	0.000739	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.000685	0.000737	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000672	0.000723	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—COMT—conduct disorder	0.000671	0.000721	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—MAOA—conduct disorder	0.000666	0.000716	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HTR2A—conduct disorder	0.000629	0.000677	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.000624	0.000671	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HTR2A—conduct disorder	0.000616	0.000662	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.000608	0.000654	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—EP300—conduct disorder	0.000576	0.00062	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000565	0.000608	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—COMT—conduct disorder	0.000545	0.000586	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—MAOA—conduct disorder	0.000541	0.000582	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000539	0.000579	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.000486	0.000523	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.000454	0.000488	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.000447	0.000481	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000397	0.000427	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000369	0.000397	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EP300—conduct disorder	0.000333	0.000358	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EP300—conduct disorder	0.000326	0.000351	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—EP300—conduct disorder	0.000288	0.000309	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000285	0.000307	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000258	0.000277	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EP300—conduct disorder	0.000241	0.000259	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.000237	0.000255	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—EP300—conduct disorder	0.000234	0.000251	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.00021	0.000226	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EP300—conduct disorder	0.000195	0.00021	CbGpPWpGaD
